CGCN GROUP, LLC

Lobbying for ALVOGEN, INC. · Pharmaceuticals company

Filing Registration

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 15, 2025

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Lobbying activity 1

Health Issues

Issues related to public health and domestic manufacturing.

Foreign interests disclosed 1

Section 7 of the LD-2: foreign entities that own part of the client, paid toward this lobbying, or stand to benefit from it.

ALVOGEN LUX HOLDINGS SARL

Luxembourg · 1736 Senningerberg · owns 100% of the client · contributed $0.00

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.